FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 4, 2014, Pages 297-305

  Liu, Youhong ^a   Gong, Zhicheng ^a   Sun, Lunquan ^a   Li, Xiong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

AR; DNA replication; FOXM1; Transcription factor; Transcription regulation

Indexed keywords

ANTINEOPLASTIC AGENT; BICALUTAMIDE; CELL CYCLE PROTEIN 6; METRIBOLONE; PROTEIN INHIBITOR; SIOMYCIN A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; REGULATORY MECHANISM;

AR; DNA REPLICATION; FOXM1; TRANSCRIPTION FACTOR; TRANSCRIPTION REGULATION;

CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA REPLICATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; NUCLEAR PROTEINS; PEPTIDES; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

EID: 84896951085     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.02.016     Document Type: Article

References (25)

1. Crawford E.D. Epidemiology of prostate cancer. Urology 2003, 62:3-12.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63:11-30.
3. Alva A., Hussain M. The changing natural history of metastatic prostate cancer. Cancer J. 2013, 19:19-24.
4. Wierstra I., Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol. Chem. 2007, 388:1257-1274.
5. Sullivan C., Liu Y., Shen J., Curtis A., Newman C., Hock J.M., Li X. Novel interactions between FOXM1 and CDC25A regulate the cell cycle. PLoS One 2012, 7:e51277.
6. Laoukili J., Alvarez-Fernandez M., Stahl M., Medema R.H. FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner. Cell Cycle 2008, 7:2720-2726.
7. Chandran U.R., Ma C., Dhir R., Bisceglia M., Lyons-Weiler M., Liang W., Michalopoulos G., Becich M., Monzon F.A. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007, 7:64.
8. Kalin T.V., Wang I.C., Ackerson T.J., Major M.L., Detrisac C.J., Kalinichenko V.V., Lyubimov A., Costa R.H. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res. 2006, 66:1712-1720.
9. Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. Adv. Cancer Res. 2013, 118:97-398.
10. Radhakrishnan S.K., Bhat U.G., Hughes D.E., Wang I.C., Costa R.H., Gartel A.L. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res. 2006, 66:9731-9735.
11. Pandit B., Gartel A.L. New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer. Prostate 2010, 70:825-833.
12. Borlado L.R., Mendez J. CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 2008, 29:237-243.
13. Blow J.J., Gillespie P.J. Replication licensing and cancer-a fatal entanglement?. Nat. Rev. Cancer 2008, 8:799-806.
14. Yan Z., DeGregori J., Shohet R., Leone G., Stillman B., Nevins J.R., Williams R.S. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:3603-3608.
15. Jin F., Fondell J.D. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression. Nucleic Acids Res. 2009, 37:4826-4838.
16. Mallik I., Davila M., Tapia T., Schanen B., Chakrabarti R. Androgen regulates Cdc6 transcription through interactions between androgen receptor and E2F transcription factor in prostate cancer cells. Biochim. Biophys. Acta 2008, 1783:1737-1744.
17. Myatt S.S., Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 2007, 7:847-859.
18. Wang X., Kiyokawa H., Dennewitz M.B., Costa R.H. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16881-16886.
19. MacVicar G.R., Hussain M.H. Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer. Curr. Opin. Oncol. 2013, 25:252-260.
20. Ohtani K., Tsujimoto A., Ikeda M., Nakamura M. Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene 1998, 17:1777-1785.
21. Murthy S., Wu M., Bai V.U., Hou Z., Menon M., Barrack E.R., Kim S.H., Reddy G.P. Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase. PLoS One 2013, 8:e56692.
22. Litvinov I.V., Vander Griend D.J., Antony L., Dalrymple S., De Marzo A.M., Drake C.G., Isaacs J.T. Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15085-15090.
23. Georges A.B., Benayoun B.A., Caburet S., Veitia R.A. Generic binding sites, generic DNA-binding domains: where does specific promoter recognition come from?. FASEB J. 2010, 24:346-356.
24. Magnani L., Eeckhoute J., Lupien M. Pioneer factors: directing transcriptional regulators within the chromatin environment. Trends Genet. 2011, 27:465-474.
25. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.